Adaptimmune Therapeutics Plc Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de Adaptimmune Therapeutics Plc?
El Est. EPS Q / Q de Adaptimmune Therapeutics Plc es 0.00%
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Adaptimmune Therapeutics Plc
¿Qué hace Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Empresas con est. eps q / q similar a Adaptimmune Therapeutics Plc
- Prestige Estates Projects tiene Est. EPS Q / Q de -0.40%
- Cigna tiene Est. EPS Q / Q de -0.35%
- Can Fin Homes tiene Est. EPS Q / Q de -0.33%
- Teleflex tiene Est. EPS Q / Q de -0.28%
- Ipca Laboratories tiene Est. EPS Q / Q de -0.24%
- Zebra Technologies tiene Est. EPS Q / Q de -0.22%
- Adaptimmune Therapeutics Plc tiene Est. EPS Q / Q de 0.00%
- Teledyne Technologies Inc tiene Est. EPS Q / Q de 0.22%
- Universal Health Services tiene Est. EPS Q / Q de 0.34%
- Idexx Laboratories tiene Est. EPS Q / Q de 0.49%
- Discover Services tiene Est. EPS Q / Q de 0.55%
- United Parcel Service tiene Est. EPS Q / Q de 0.56%
- TMX tiene Est. EPS Q / Q de 0.56%